Related Experiment Video
Updated: Jul 17, 2026

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Nutrition for children with cholestatic liver disease
E Leonie Los1, Sabina Lukovac, Anniek Werner
1Pediatric Gastroenterology/Research Laboratory of Pediatrics, Department of Pediatrics, University Medical Center Groningen, University of Groningen, NL-9700 RB Groningen, The Netherlands.
Insights
Optimizing nutrition is vital for children with cholestatic liver disease (CLD) to improve growth and reduce mortality risk. Tailored nutritional strategies, informed by advanced nutrient metabolism studies, are crucial for these patients.
Area of Science:
- Pediatric Gastroenterology and Hepatology
- Nutritional Science
- Biochemistry
Background:
- Cholestatic liver disease (CLD) in children significantly impairs nutritional status, growth, and development, increasing morbidity and mortality risks.
- Nutritional status is a key predictor of clinical outcomes in pediatric patients with CLD awaiting liver transplantation.
- The heterogeneity of CLD necessitates individualized nutritional management strategies.
Purpose of the Study:
- To highlight the critical role of nutritional status in pediatric cholestatic liver disease.
- To review current understanding and future directions in assessing nutrient metabolism in CLD.
- To emphasize the need for tailor-made nutritional therapies in children with CLD.
Main Methods:
- Utilized stable isotope-labeled triglycerides and fatty acids in animal models and human studies to investigate fat absorption.
- Reviewed existing literature on nutrient metabolism and absorption in pediatric CLD.
- Discussed the potential application of isotope-labeled macronutrients (carbohydrates, proteins) for future assessments.
Main Results:
- Stable isotope studies have elucidated fat absorption mechanisms in both physiological and cholestatic conditions.
- Current understanding of carbohydrate and protein metabolism in pediatric CLD requires further investigation.
- Nutritional status directly impacts the prognosis of children with CLD.
Conclusions:
- Optimizing nutritional status is essential for improving outcomes in children with CLD.
- Further research using stable isotopes for carbohydrates and proteins will enable more precise nutritional assessments.
- Development of personalized nutritional therapies is paramount for managing pediatric CLD effectively.
Abstract:
Cholestatic liver disease (CLD) in children negatively affects nutritional status, growth and development, which all lead to an increased risk of morbidity and mortality. This is illustrated by the fact that the clinical outcome of children with CLD awaiting a liver transplantation is in part predicted by their nutritional status, which is integrated in the pediatric end-stage liver disease model. Preservation of the nutritional status becomes more relevant as the number of patients waiting for liver transplantation increases and the waiting time for a donor organ becomes prolonged. Nutritional strategies are available to optimize feeding of children with CLD. Patients with CLD, however, form a heterogeneous group and the clinical manifestations of their disease vary. This makes a tailor-made approach for these children crucial. Not all aspects of nutrient metabolism and absorption in children with CLD are well understood and studied. Experiments with stable isotope-labeled triglycerides and fatty acids have provided essential information about fat absorption under physiological and cholestatic conditions in animal models and humans. We expect that in the future, tests using other isotope-labeled macronutrients, i.e. carbohydrates and proteins, can be used to further assess nutritional status of children with CLD, thereby creating tailor-made nutritional therapies.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Lipids: Dietary Sources and Requirements

